Nektar Therapeutics (NKTR)

31.97
NASDAQ : Health Technology
Prev Close 32.07
Day Low/High 31.87 / 32.25
52 Wk Low/High 29.22 / 69.76
Avg Volume 1.52M
Exchange NASDAQ
Shares Outstanding 174.31M
Market Cap 5.59B
EPS 4.00
P/E Ratio 8.14
Div & Yield N.A. (N.A)

Latest News

GE and Kohl's Are Among 2 Stocks Poised For Reversal

GE and Kohl's Are Among 2 Stocks Poised For Reversal

These names are showing bullish and bearish technical patterns over the past week.

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.

Rev's Forum: Problems Simmer, but It's Still Too Early for a Bearish Bias

Rev's Forum: Problems Simmer, but It's Still Too Early for a Bearish Bias

It is premature to think that this market has hit a top until there is further evidence in the price action.

Ophthotech Soars After Third-Quarter Results -- Biotech Movers

Ophthotech Soars After Third-Quarter Results -- Biotech Movers

The New York-based firm reported net income of $5.25 per share, compared with a net loss of $1.71 per share, in the same period a year ago.

Traders Are Aggressively Fading the Open

Traders Are Aggressively Fading the Open

But what will be most important is whether support stays strong and the buyers show interest in the afternoon.

Rev's Forum: Don't Just Sit There, Do Something!

Rev's Forum: Don't Just Sit There, Do Something!

Why not buy something and try to make some money rather than waste time predicting how this will all come to an ugly end?

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Finding the stocks that have changed direction.

Retail, Financials, Speculative Biotechs Getting Hit

This morning I warned about an overbought group of market sectors/leaders.   Thus far, (recent leaders) retail and financials are being taken out to the woodshed.   Speculative biotech, like Intrexon  , Portola Pharmaceuticals  , SAGE Therapeutics  ...

My Takeaways and Observations

"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax.   A consecutive nine-day market drop was snapped as we regained most that was lost in that period.   Today was a great day. (Boy, would I like to annualize the pe...

The Good, the Bad and the Ugly

"You see, in this world there's two kinds of people, my friend: Those with loaded guns and those who dig. You dig." -- Blondie in "The Good, the Bad and the Ugly." I did very little today.   Markets were higher from the get-go and seemed "stuck" nea...

Rev's Forum: Let's See If Bulls Can Sustain Friday's Momentum

Rev's Forum: Let's See If Bulls Can Sustain Friday's Momentum

The big issue is if the market can build on Friday's jobs good news.

Don't Roll the Dice on Central Bank News

Don't Roll the Dice on Central Bank News

The bears are trying it out on the Bank of England news today, but they may get squeezed.

Using My Metal Detector Amid Gold and Silver Strength

Using My Metal Detector Amid Gold and Silver Strength

Computer programming has found that buying bad-news dips is a consistent winner.

Today's Takeaways and Observations (Early Edition)

I started the day today by dissing the banks.                  Then, I unfriended Facebook (FB) by making it my Short Trade of the Week. Finally, I offered another critical post about auto stocks. Hey, at least I'm consistent! And at least I like Op...

My Takeaways and Observations

I remain "all in short," positioned on Friday afternoon.   My message for the day this morning? "Don't worship at the church of what's happening now."  The key insight today was the flight to safety. More risk off might lie ahead. Thanks for the nic...

Novice Trade: Nektar Therapeutics

Novice Trade: Nektar Therapeutics

Plus an update on the Urban Outfitters trade from yesterday.

My Takeaways and Observations

What a weekend at the First Annual RealMoneyPro Golf Tournament and Conference! Unprecedented fun!!  Here is why I am "all in" short.  I made some important portfolio changes today, selling six core long investments.  I am at my largest net short po...

Biotech Breakout

Given my risk-averse profile, I made the unusual move last week of buying a basket of biotech stocks. And yesterday, I noted that Biotech Could Be Close to a 'Double Bottom': "I recently created a basket of a dozen speculative and conservative biote...

9 Rising Stocks in a Falling Market

Stocks are near the day's lows as I write this -- and an old traders' adage is to "buy what's green in a flow of red." That's not a strategy I plan to employ today. But for contrarians who are looking for some trades in a potential market turnaround...

Buying Biotechs

The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...

Nektar downgraded at MKM

Disappointment Sinks In

The market is rolling over following initial confusion over the Supreme Court's Obamacare decision.

Time to Go Short

Time to Go Short

There's been an important change in the last two days, emphasized by a jump in volume to the downside.